Jalra M 850/50 Tablets for blood sugar control (60 tablets); contains two active ingredients for the management of Type 2 diabetes.
Jalra M Tablet Ingredients
Each Jalra M tablet contains:
-
Vildagliptin 50 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that improves blood sugar levels by increasing incretin levels in the blood postprandially (after meals) and during fasting.
-
Metformin 850 mg: Belongs to the biguanide class; it reduces glucose production by the liver and glucose absorption by the intestines. It also improves insulin sensitivity and increases the tissues' ability to utilize glucose.
What is Jalra-M 50mg 850mg used for?
Jalra M pills are used in the treatment of Type 2 diabetes, alongside exercise and a healthy diet, to control blood sugar levels.
Dosage of Jalra M Tablets
-
The doctor determines the appropriate dosage of Jalra M tablets.
-
The starting dose may be one tablet twice daily; once in the morning and once in the evening.
Jalra-M 50/850 Side Effects
-
Tremors.
-
Dizziness.
-
Headache.
-
Nausea.
-
Hypoglycemia (low blood sugar).
Contraindications
Jalra M should not be used in the following cases:
-
Hypersensitivity to any of its components.
-
Renal impairment (kidney failure).
-
Congestive heart failure.
-
Metabolic acidosis.
-
Acute or chronic diseases that may cause tissue hypoxia, such as heart or respiratory failure, a recent heart attack, or shock.
-
Alcohol intoxication.
-
Breastfeeding.
Warnings and Precautions
Caution must be exercised and a doctor consulted before taking Jalra M, especially in cases of:
-
Hepatic impairment (liver problems).
-
Pancreatitis.
-
Pregnancy.
Drug Interactions
Inform your pharmacist or doctor of any medications you are taking before using Jalra M, especially:
-
Diuretics.
-
Hypertension medications.
-
Non-steroidal anti-inflammatory drugs (NSAIDs).
Storage and Handling
-
Keep out of reach of children.
-
Store in its original packaging away from moisture.
-
Do not use it after the expiration date.